Announce Date | 01/30/2025 |
EPS Normalized Actual | $6.1 (Beat by $0.16) |
EPS GAAP Actual | $6.1 (Beat by $0.16) |
Revenue Actual | $11.395B |
Revenue Surprise | Beat by $11395M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 36.3 | 14.38 | 35.60007 | 37.36258 | 1 |
Dec 2028 | 35.52 | 14.7 | 34.93574 | 36.07251 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 4.79 | 4.79 | 11.395B | 4.47% | 11395M |
FQ3 2024 (Sep 2024) | 4.27 | 4.27 | 10.598B | -0.84% | 10598M |
FQ2 2024 (Jun 2024) | 4.05 | 4.05 | 10.541B | 100% | 10541M |
FQ1 2024 (Mar 2024) | 3.48 | 3.48 | 10.345B | -3.53% | 10345M |
FQ4 2023 (Dec 2023) | 4.21 | 4.21 | 10.886B | 1.92% | 10886M |
FQ3 2023 (Jul 2023) | 3.84 | 3.84 | 10.687B | -2.65% | 10687M |
FQ1 2023 (Mar 2023) | 3.34 | 3.34 | 10.71B | 100% | 10710M |
FQ4 2022 (Oct 2022) | 3.81 | 3.81 | 10.677B | 100% | 10677M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 7.30202 | -- | 7.14199 | 7.4176 | 7 |
FQ3 2026 (Sep 2026) | 6.40961 | -- | 6.26914 | 6.51107 | 7 |
FQ2 2026 (Jun 2026) | 6.28479 | -- | 6.14705 | 6.38427 | 7 |
FQ1 2026 (Mar 2026) | 5.95299 | -- | 5.82253 | 6.04722 | 7 |
FQ4 2025 (Dec 2025) | 6.53256 | 26.67 | 6.38939 | 6.63596 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 12.96B | -- | 12.74B | 13.11B | 9 |
FQ3 2026 (Sep 2026) | 12.09B | -- | 11.89B | 12.24B | 6 |
FQ2 2026 (Jun 2026) | 11.96B | -- | 11.76B | 12.11B | 5 |
FQ1 2026 (Mar 2026) | 11.63B | -- | 11.43B | 11.77B | 5 |
FQ4 2025 (Dec 2025) | 11.96B | 4.72 | 11.76B | 12.11B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 4.79 | 4.79 | 100% | |
FQ3 2024 (Sep 2024) | 4.27 | 4.27 | 100% | |
FQ2 2024 (Jun 2024) | 4.05 | 4.05 | 100% | |
FQ1 2024 (Mar 2024) | 3.48 | 3.48 | 100% | |
FQ4 2023 (Dec 2023) | 4.21 | 4.21 | 100% | |
FQ3 2023 (Jul 2023) | 3.84 | 3.84 | 100% | |
FQ1 2023 (Mar 2023) | 3.34 | 3.34 | 100% | |
FQ4 2022 (Oct 2022) | 3.81 | 3.81 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $11.4B | $11395M | 100% |
FQ3 2024 (Sep 2024) | $0B | $10.6B | $10598M | 100% |
FQ2 2024 (Jun 2024) | $0B | $10.54B | $10541M | 100% |
FQ1 2024 (Mar 2024) | $0B | $10.35B | $10345M | 100% |
FQ4 2023 (Dec 2023) | $0B | $10.89B | $10886M | 100% |
FQ3 2023 (Jul 2023) | $0B | $10.69B | $10687M | 100% |
FQ1 2023 (Mar 2023) | $0B | $10.71B | $10710M | 100% |
FQ4 2022 (Oct 2022) | $0B | $10.68B | $10677M | 100% |